Trials / Completed
CompletedNCT00790985
Efficacy of Flavocoxid 500 mg Compared With Naproxen 500 mg in Subjects With Moderate-severe Osteoarthritis of the Knee
Phase 3. Efficacy of Flavocoxid Compared With Naproxen in Subjects With Moderate-severe Osteoarthritis (OA) of the Knee
- Status
- Completed
- Phase
- N/A
- Study type
- Interventional
- Enrollment
- 223 (actual)
- Sponsor
- Primus Pharmaceuticals · Industry
- Sex
- All
- Age
- 35 Years – 75 Years
- Healthy volunteers
- Not accepted
Summary
To compare flavocoxid with naproxen for patients with moderate to severe osteoarthritis of the knee.
Detailed description
Efficacy of flavocoxid 500 mg compared with naproxen 500 mg in subjects with moderate-severe osteoarthritis of the knee.
Conditions
Interventions
| Type | Name | Description |
|---|---|---|
| DIETARY_SUPPLEMENT | flavocoxid | medical food |
| DRUG | Naproxen | antiinflammatory drug |
Timeline
- Start date
- 2008-01-01
- Primary completion
- 2008-08-01
- Completion
- 2008-08-01
- First posted
- 2008-11-14
- Last updated
- 2022-11-01
- Results posted
- 2022-11-01
Source: ClinicalTrials.gov record NCT00790985. Inclusion in this directory is not an endorsement.